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Abstract
In response to a large local school-based outbreak of tuberculosis, we have been eval-
uating the utility of microarray bacterial genomic analysis in outbreak management.
After initial comparison of the isolate from the index case with Mycobacterium tuber-
culosis H37Rv, it was possible to design robust PCRs directed towards strain-speciﬁc
deletions. Rapid PCR analysis of isolates proved valuable in determining whether or
not other isolates were compatible with the outbreak strain and further microarray
studies revealed genetic markers that could be used to discriminate between locally
circulating strains. We suggest that this approach forms the basis for developing rapid
local genotyping schemes applicable to M. tuberculosis and that application to other
pathogens warrants consideration. Copyright  2002 John Wiley & Sons, Ltd.
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We have been exploring the degree to which
microarray analyses can be applied to investigate
outbreak strains of Mycobacterium tuberculosis.
The work was provoked by a large local
school-based outbreak of tuberculosis and we
identiﬁed the following objectives in asking what
microarray analyses might have to offer in this
context:
1. To determine whether the outbreak strain carries
genetic markers that could be used for its rapid
and speciﬁc detection in clinical samples.
2. To study the genome of the outbreak strain
for distinctive features that might explain the
clinical and epidemiological features of the
outbreak.
Our initial results gave a strong indication that
microarray genomic analysis can provide the basis
for rapid recognition of tuberculosis cases as out-
break or non-outbreak cases by strain-speciﬁc PCR,
and that a coherent view of the genealogy of locally
circulating strains may be obtained. This informa-
tion has proved of considerable interest to the local
public health control effort, principally because
results can be obtained on a time-scale com-
patible with the disease control decision-making
process; contrasting with the retrospective analy-
sis produced by most conventional strain-typing
studies. Our preliminary work indicates that the
approach may be applicable to the control effort
of any local tuberculosis problem and that it might
also be applicable to rapid resolution of public
health issues relating to other infections. Here
we review the background to, and key features
of, this approach and discuss its potential further
applications.
Microarrays have been used extensively to study
relationships between bacterial strains and can pro-
vide a coherent view of relatedness and phy-
logeny. One study on a set of M. tuberculosis iso-
lates for which epidemiological data were avail-
able included some microarray work but only three
related isolates were studied (5). As far we are
aware, the utility of this approach for outbreak
analysis and management has not been evalu-
ated previously.
The approach we have established is illustrated
in Figure 1. The initial rate-limiting step is obtain-
ing sufﬁcient genomic DNA for the ﬁrst round
array hybridization. In the ORF amplicon-based
array we have used, this reveals potential gene dele-
tions (and duplications). These are then conﬁrmed
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Figure 1. Microarray-derived genotyping for public health. An iterative process is outlined in which array hybridizations
are used to screen for strain-speciﬁc genetic markers. Dashed lines indicate stages occurring after the ﬁrst round array
analysis. As more markers are identiﬁed, so a more robust locally applicable genotyping scheme is obtained. ∗H37Rv in our
case, but ideally this should reﬂect the known gene pool for the M. tuberculosis complex
by diagnostic PCR. Once this has been achieved,
speciﬁc deletion-targeted PCRs can be designed
and evaluated. Since the primers for such analy-
ses are already available for the manufacture of the
arrays, this evaluation is very rapid and the resul-
tant selected PCRs can be applied directly to new
isolates or to acid-fast bacilli-positive specimens.
Such analyses might also be possible on smear-
negative samples, although the public health issues
are lessened here because of the weaker association
with transmission in such patients. Even when only
one or two deletion-directed PCRs have been eval-
uated, these can be useful, since the detection in a
test isolate of a gene that has been deleted in the
outbreak strain makes it unlikely (but not impossi-
ble) that the former came from the outbreak. In our
outbreak strain, from an initial 11 possible deletion
loci compared to H37Rv, ﬁve robust diagnostic
PCRs were established. One borderline weak array
signal proved not to be a deletion and three of the
deletions involved two adjacent genes. It should be
noted that PCR results can be interpreted with con-
ﬁdence, as analyses yield small or large amplicons
depending, respectively, on the presence or absence
of the target deletion.
In order to determine the discriminatory power
of detecting strain-speciﬁc deletions by PCR, we
applied this analytical approach to local isolates
from a period up to 2 years prior to the out-
break. These represented all the main IS6110 RFLP
types isolated and were tested blind, together with
other isolates from the outbreak. The ﬁve PCRs
unequivocally detected all of the outbreak iso-
lates (identiﬁed as such by both epidemiological
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and RFLP data). Two strains with RFLP patterns
indistinguishable from the outbreak strain, and con-
sidered to reﬂect presence of the strain in the com-
munity prior to the outbreak, also tested positive for
all ﬁve deletions. Of the other strains tested (∼50),
isolates with three or less deletions in common
with the outbreak strain showed no epidemiolog-
ical connection with the outbreak. A large group
with three outbreak strain deletions in common
with each other included diverse RFLP types.
We also applied PCR analysis to new local iso-
lates where our public health colleagues wanted
to know whether the case was connected to the
outbreak. In each of the seven isolates tested
so far, absence of two or more outbreak dele-
tions has allowed us to unequivocally exclude
this possibility.
Both applications of the deletion-directed PCRs
allowed us to recognize isolates that we felt were
appropriate for further microarray analyses. The
results of these analyses were useful, ﬁrstly in iden-
tifying further genetic markers of locally circulat-
ing strains and secondly in allowing us to recognize
possible genealogies of the isolates. When matched
with the epidemiological and clinical data, it was
possible in several cases to construct coherent
sequences for the evolution of the strains observed.
While a more detailed analysis of these results
is in progress, our initial impression is that this
iterative analytical approach rapidly yields infor-
mation that can inform the public health control
process. Further, with the identiﬁcation of addi-
tional marker genes for locally circulating strains,
a more and more discriminatory panel of diagnos-
tic PCRs becomes available for rapid local iso-
late/specimen analysis. A major part of our further
analysis will include a detailed review of the rela-
tionships between our deletion analyses and estab-
lished typing scheme results.
As far as we are aware, microarrays have not
previously been used to facilitate bacterial strain
recognition during the course of an outbreak.
Recent bacterial genomics studies have mainly con-
centrated on the evolution of currently circulating
stains of the M. tuberculosis complex [5], Staphy-
lococcus aureus [3], Streptococcus pyogenes [6],
Streptococcus pneumoniae [4], Escherichia coli
O157 [1] and Campylobacter jejuni [2]. Apart
from PCR studies to validate the microarray results,
these studies have used full genomic analyses
throughout. While this presents little problem for
rapidly growing bacteria, requirement for substan-
tial quantities of genomic DNA places major time
and logistic constraints on the analysis of M. tuber-
culosis isolates; the PCR analyses we have estab-
lished effectively circumvent this problem.
The utility of the initial microarray analysis of an
outbreak strain is of course, limited by the degree to
which the array reﬂects the gene pool of the target
organism. While it is generally agreed that lateral
gene transfer is not a signiﬁcant phenomenon in the
M. tuberculosis complex (hence incoming ‘novel’
genes should not present a problem), sequencing
has demonstrated that CDC1551 has at least 20
more ORFs than H37Rv and these were not rep-
resented in our analysis. Ideally, we would like to
represent the M. tuberculosis gene pool completely
in future analyses, but the extent of this (includ-
ing the possible presence of ‘extra’ genes in our
outbreak strain) has yet to be determined.
The ORF amplicon microarray we used here
offers two major advantages: (a) it is a relatively
low-cost system; and (b) initial primer sets for
downstream analysis are immediately available. In
comparison to oligonucleotide arrays, this approach
has lower resolving power (i.e. the deletions have
to involve a substantial proportion of the amplicon)
and presents fewer opportunities for internal result
validation.
Analysis of our results in relation to the bio-
logical properties of the outbreak strain is at a
very early stage. None of the deleted ORFs have
provided a clear clue to the strain’s pathogenic-
ity. Interestingly, none of the possible progenitor
strains detected amongst community isolates seems
to have spread extensively, so it is attractive to
speculate that genomic alterations between these
and the outbreak strain may have been critical to its
epidemic potential. Global analyses of gene dele-
tions in larger strain sets of M. tuberculosis and
other pathogens will also allow us to deﬁne a
minimum gene set compatible with virulence. In
the future, microarray analysis of gene expression
in the outbreak strain may provide a further level
at which features of the outbreak strain might be
related to its public health signiﬁcance.
At present there are two key questions relating
to the approach we have established; does
the approach offer an economic and practical
alternative or complement to other epidemiological
isolate analytical tools, and can the approach be
usefully applied to other pathogens?
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